←
Nephrology Times1,757 posts
Nephrology Times avatar

Nephrology Times

@Neph_Times

Delivering the latest news in nephrological treatments and technologies with the goal of better informing care decisions and improving patient outcomes

◷ Joined November 2023▧ 1,211 Photos and videos
Nephrology Times avatar
Nephrology Times@Neph_Times·May 28

🔗 buff.ly/yazOR9r Finerenone, already approved for adults with CKD associated with type 2 diabetes, has been granted Priority Review by the FDA for adults with CKD and type 1 diabetes. #nephrology #nephtwitter #ckd #kidneydisease #diabetes